Cargando…
The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
AIMS: Patient reported outcomes (PROs) are gradually being incorporated into daily practice to assess individual health‐related quality of life (QOL). However, despite accumulating evidence of the prognostic utility of heart failure (HF)‐specific QOL indices, evidence on the generic QOL score is sca...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053171/ https://www.ncbi.nlm.nih.gov/pubmed/36510693 http://dx.doi.org/10.1002/ehf2.14270 |
_version_ | 1785015348946272256 |
---|---|
author | Seo, Masahiro Watanabe, Tetsuya Yamada, Takahisa Yano, Masamichi Hayashi, Takaharu Nakagawa, Akito Nakagawa, Yusuke Tamaki, Shunsuke Yasumura, Yoshio Sotomi, Yohei Hikoso, Shungo Nakatani, Daisaku Fukunami, Masatake Sakata, Yasushi |
author_facet | Seo, Masahiro Watanabe, Tetsuya Yamada, Takahisa Yano, Masamichi Hayashi, Takaharu Nakagawa, Akito Nakagawa, Yusuke Tamaki, Shunsuke Yasumura, Yoshio Sotomi, Yohei Hikoso, Shungo Nakatani, Daisaku Fukunami, Masatake Sakata, Yasushi |
author_sort | Seo, Masahiro |
collection | PubMed |
description | AIMS: Patient reported outcomes (PROs) are gradually being incorporated into daily practice to assess individual health‐related quality of life (QOL). However, despite accumulating evidence of the prognostic utility of heart failure (HF)‐specific QOL indices, evidence on the generic QOL score is scarce, especially in patients with HF with preserved ejection fraction (HFpEF). METHODS AND RESULTS: Patient data were extracted from the Prospective mUlticenteR obServational stUdy of patIenTs with Heart Failure with Preserved Ejection Fraction (PURSUIT HFpEF) study. EuroQol 5 dimensions 5‐level (EQ‐5D‐5L) data were obtained at discharge to evaluate patients' health‐related QOL. The study population (n = 864) was divided into tertiles based on their EQ‐5D‐5L index as follows: low EQ‐5D‐5L 0.038–0.664 (n = 287), middle EQ‐5D‐5L 0.665–0.867 (n = 293), and high EQ‐5D‐5L 0.871–1.000 (n = 284). A total of 206 patients died over a mean follow‐up period of 2.0 ± 1.2 years. Kaplan–Meier analysis revealed that the risk of mortality increased with the tertile of the EQ‐5D‐5L index (34% vs. 23% vs. 14%, P < 0.001). Cox multivariable analysis revealed that patients with EQ‐5D‐5L index in the low and middle tertiles had a significantly greater risk of mortality than those with EQ‐5D‐5L index in the high tertile [low EQ‐5D‐5L: adjusted hazard ratio (HR): 1.81 (1.12–2.92), P = 0.002, middle EQ‐5D‐5L: adjusted HR 1.91 (1.21–3.03), P = 0.006]. Among the dimensions of EQ‐5D‐5L, mobility (P = 0.014), self‐care (P = 0.023) and usual activities (P = 0.008) were significant factors associated with all‐cause mortality after multivariable adjustment. CONCLUSIONS: EQ‐5D‐5L is useful tool for risk stratification in patients with HFpEF. |
format | Online Article Text |
id | pubmed-10053171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100531712023-03-30 The clinical relevance of quality of life in heart failure patients with preserved ejection fraction Seo, Masahiro Watanabe, Tetsuya Yamada, Takahisa Yano, Masamichi Hayashi, Takaharu Nakagawa, Akito Nakagawa, Yusuke Tamaki, Shunsuke Yasumura, Yoshio Sotomi, Yohei Hikoso, Shungo Nakatani, Daisaku Fukunami, Masatake Sakata, Yasushi ESC Heart Fail Original Articles AIMS: Patient reported outcomes (PROs) are gradually being incorporated into daily practice to assess individual health‐related quality of life (QOL). However, despite accumulating evidence of the prognostic utility of heart failure (HF)‐specific QOL indices, evidence on the generic QOL score is scarce, especially in patients with HF with preserved ejection fraction (HFpEF). METHODS AND RESULTS: Patient data were extracted from the Prospective mUlticenteR obServational stUdy of patIenTs with Heart Failure with Preserved Ejection Fraction (PURSUIT HFpEF) study. EuroQol 5 dimensions 5‐level (EQ‐5D‐5L) data were obtained at discharge to evaluate patients' health‐related QOL. The study population (n = 864) was divided into tertiles based on their EQ‐5D‐5L index as follows: low EQ‐5D‐5L 0.038–0.664 (n = 287), middle EQ‐5D‐5L 0.665–0.867 (n = 293), and high EQ‐5D‐5L 0.871–1.000 (n = 284). A total of 206 patients died over a mean follow‐up period of 2.0 ± 1.2 years. Kaplan–Meier analysis revealed that the risk of mortality increased with the tertile of the EQ‐5D‐5L index (34% vs. 23% vs. 14%, P < 0.001). Cox multivariable analysis revealed that patients with EQ‐5D‐5L index in the low and middle tertiles had a significantly greater risk of mortality than those with EQ‐5D‐5L index in the high tertile [low EQ‐5D‐5L: adjusted hazard ratio (HR): 1.81 (1.12–2.92), P = 0.002, middle EQ‐5D‐5L: adjusted HR 1.91 (1.21–3.03), P = 0.006]. Among the dimensions of EQ‐5D‐5L, mobility (P = 0.014), self‐care (P = 0.023) and usual activities (P = 0.008) were significant factors associated with all‐cause mortality after multivariable adjustment. CONCLUSIONS: EQ‐5D‐5L is useful tool for risk stratification in patients with HFpEF. John Wiley and Sons Inc. 2022-12-12 /pmc/articles/PMC10053171/ /pubmed/36510693 http://dx.doi.org/10.1002/ehf2.14270 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Seo, Masahiro Watanabe, Tetsuya Yamada, Takahisa Yano, Masamichi Hayashi, Takaharu Nakagawa, Akito Nakagawa, Yusuke Tamaki, Shunsuke Yasumura, Yoshio Sotomi, Yohei Hikoso, Shungo Nakatani, Daisaku Fukunami, Masatake Sakata, Yasushi The clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
title | The clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
title_full | The clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
title_fullStr | The clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
title_full_unstemmed | The clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
title_short | The clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
title_sort | clinical relevance of quality of life in heart failure patients with preserved ejection fraction |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053171/ https://www.ncbi.nlm.nih.gov/pubmed/36510693 http://dx.doi.org/10.1002/ehf2.14270 |
work_keys_str_mv | AT seomasahiro theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT watanabetetsuya theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT yamadatakahisa theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT yanomasamichi theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT hayashitakaharu theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT nakagawaakito theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT nakagawayusuke theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT tamakishunsuke theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT yasumurayoshio theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT sotomiyohei theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT hikososhungo theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT nakatanidaisaku theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT fukunamimasatake theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT sakatayasushi theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT theclinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT seomasahiro clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT watanabetetsuya clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT yamadatakahisa clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT yanomasamichi clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT hayashitakaharu clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT nakagawaakito clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT nakagawayusuke clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT tamakishunsuke clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT yasumurayoshio clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT sotomiyohei clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT hikososhungo clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT nakatanidaisaku clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT fukunamimasatake clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT sakatayasushi clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction AT clinicalrelevanceofqualityoflifeinheartfailurepatientswithpreservedejectionfraction |